MEDIA & INVESTORS

Wilson Therapeutics is committed to improving lives of patients with Wilson Disease through development of new treatment options. Wilson Therapeutics is committed to the development of its lead product, WTX101, which is initially developed as a new treatment for Wilson Disease.

For more information about the company, please email us at info@wilsontherapeutics.com.